Blume-Jensen Peter
SEC insider (Form 3/4/5 filer). CIK 0001950499. President and CEO at Acrivon Therapeutics, Inc. (ACRV). 33 reported Form 4/5 transactions since Sep 2024; latest on Aug 25, 2026. Located in WATERTOWN, MA.
Companies Blume-Jensen Peter has filed insider reports for
- Acrivon Therapeutics, Inc. (ACRV): Director, Officer, President and CEO
Blume-Jensen Peter
CIK: 0001950499
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Acrivon Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (33 total)
- Aug 25, 2026ACRV
Acrivon Therapeutics, Inc.
SaleDirect14K shares at avg. $2.21$31K - Aug 18, 2026ACRV
Acrivon Therapeutics, Inc.
SaleIndirect484 shares at avg. $2.01$972.84 - Aug 18, 2026ACRV
Acrivon Therapeutics, Inc.
SaleDirect1.2K shares at avg. $2.01$2K - May 21, 2026ACRV
Acrivon Therapeutics, Inc.
Tax PaymentDirect13.7K shares at avg. $1.79$25K - May 18, 2026ACRV
Acrivon Therapeutics, Inc.
AwardDirect180.1K shares- - May 18, 2026ACRV
Acrivon Therapeutics, Inc.
AwardIndirect72.7K shares- - May 14, 2026ACRV
Acrivon Therapeutics, Inc.
Tax PaymentDirect1.3K shares at avg. $1.92$2K - May 14, 2026ACRV
Acrivon Therapeutics, Inc.
Tax PaymentIndirect490 shares at avg. $1.92$940.8 - Mar 1, 2026ACRV
Acrivon Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
417.2K shares- - Mar 1, 2026ACRV
Acrivon Therapeutics, Inc.
AwardIndirectStock Option (Right to Buy)
185.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 25, 2026 | ACRV Acrivon Therapeutics, Inc. | Sale | 14,036 | $2.21 | $30,969 | Direct |
| Aug 18, 2026 | ACRV Acrivon Therapeutics, Inc. | Sale | 484 | $2.01 | $973 | Indirect |
| Aug 18, 2026 | ACRV Acrivon Therapeutics, Inc. | Sale | 1,229 | $2.01 | $2,470 | Direct |
| May 21, 2026 | ACRV Acrivon Therapeutics, Inc. | Tax Payment | 13,729 | $1.79 | $24,575 | Direct |
| May 18, 2026 | ACRV Acrivon Therapeutics, Inc. | Award | 180,095 | - | $0 | Direct |
| May 18, 2026 | ACRV Acrivon Therapeutics, Inc. | Award | 72,706 | - | $0 | Indirect |
| May 14, 2026 | ACRV Acrivon Therapeutics, Inc. | Tax Payment | 1,253 | $1.92 | $2,406 | Direct |
| May 14, 2026 | ACRV Acrivon Therapeutics, Inc. | Tax Payment | 490 | $1.92 | $941 | Indirect |
| Mar 1, 2026 | ACRV Acrivon Therapeutics, Inc. | Award Stock Option (Right to Buy) | 417,210 | - | - | Direct |
| Mar 1, 2026 | ACRV Acrivon Therapeutics, Inc. | Award Stock Option (Right to Buy) | 185,495 | - | - | Indirect |
1-10 of 33 transactions